Research programme: Huntington's disease therapy - NeuroSearchAlternative Names: Ion channel modulator for Huntington's disease (NSD-726) - NeuroSearch/NsDiscovery; NSD-726
Latest Information Update: 04 Dec 2013
At a glance
- Originator NeuroSearch
- Mechanism of Action Ion channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Huntington's disease
Most Recent Events
- 28 Sep 2011 Research programme: Huntington's disease therapy - NeuroSearch is available for licensing as of 28 Sep 2011. http://neurosearch.com
- 30 Mar 2011 Preclinical development is ongoing in Denmark